Skip to main content
2024 National Biotechnology Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Executive Track

Executive Track - Cell and Gene Therapies at the Intersection of Business

Executive Track - Cell and Gene Therapies at the Intersection of Business and Science

Tuesday, May 14, 2024
9:30 AM – 11:00 AM PT
Location: Franciscan A&B
Cell and gene therapies are transforming the pharma and biopharma markets even as the science behind these products advances. Roughly 30 cell and gene therapy products are currently approved within the United States, and that number is expected to climb significantly. According to Vantage Market Research, the global cell and gene therapy manufacturing market should maintain an annual growth rate of 18.2% through the rest of the decade, ultimately, attaining a value of $15.4 billion by 2030 when compared to the current market of $4.7 billion. And that growth will continue to climb after 2030. However, with growth comes pain points within key areas, e.g., global market access, development speed, and organizational capabilities.

This panel discussion will discuss the current state of cell and gene therapies and feature practical insights from global leaders on how to address these challenges. Other discussion points include business considerations at the intersection of scientific advancement and how demand for these advanced therapeutics impacts global health.

Learning Objectives:

  • This panel discussion will define the current state of the cell and gene therapy market;
  • Analyze and discuss current barriers for scientific advancement, and;
  • Examine what is needed to ensure market entry and patient access to these promising advancements.